| Literature DB >> 17164114 |
Abstract
Hepatitis C virus is a disease of major public health significance throughout the world in terms of overall morbidity and mortality and in its economic consequences and demands on medical resources. The global economic burden of this disease has yet to be fully realized. In this article the authors discuss the economic burden of hepatitis C, the economics of therapy, and the economics of its prevention and screening.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17164114 DOI： 10.1016/j.cld.2006.08.026
Source DB: PubMed Journal: Clin Liver Dis ISSN： 1089-3261 Impact factor: 6.126